A Conversion Study to Assess Safety and Efficacy of a MR4 Based Immunosuppressive Regimen in Stable Liver Recipients
Clinical trial NCT00384202 · COMPLETED
Trial details
- NCT number
- NCT00384202
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-10-01
- Primary completion
- 2007-11-01
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.